IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2020
Total Assets: $29.0M
Liabilities Breakdown FY2020
Total Liabilities: $2.4M
Asset Breakdown
Total Assets: $29.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.3M | 25.0% |
| Accounts Receivable | $133.0K | 0.5% |
| Inventory | $4.2M | 14.6% |
| Property, Plant & Equipment | $9.8M | 33.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $252.0K | 0.9% |
| Other Assets | $7.3M | 25.2% |
Liabilities Breakdown
Total Liabilities: $2.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $762.0K | 31.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.7M | 68.9% |